CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $10.32M, lower than 95% of all stocks globally
- FinancialsLow earnings quality
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.01BUSDvs all stocks (USD)
Revenue (TTM)
10.32MUSDvs all stocks (USD)
Profit Margin
0.00%52-Week Change
395.86%vs all stocks
Market Capitalization
1.01BUSDvs all stocks (USD)
Enterprise Value
634.81MUSDvs all stocks (USD)
Forward P/E
-11.07xPrice to Sales (TTM)
98.29xPrice to Book (MRQ)
2.67xEnterprise to Revenue
61.54xEnterprise to EBITDA
-6.26xProfit Margin
0.00%Operating Margin
-915.40%Return on Assets (TTM)
-17.15%Return on Equity (TTM)
-25.98%Revenue (TTM)
10.32MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.2740USDUpdated Jul 18, 2026Quarterly Revenue Growth
91.00%Gross Profit (TTM)
-72.95MUSDvs all stocks (USD)
EBITDA (TTM)
-101.47MUSDvs all stocks (USD)
Net Income (TTM)
-89.93MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
91.04%Operating Cash Flow (TTM)
-88.31MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-58.34MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
8.99MUSDFY2025 · Dec 31, 2025Operating Income
-92.78MUSDvs all stocks (USD)
Pre-tax Income
-80.61MUSDFY2025 · Dec 31, 2025Net Income
-80.61MUSDFY2025 · Dec 31, 2025EBIT
-79.91MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-79.48MUSDFY2025 · Dec 31, 2025Research & Development
73.97MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
27.81MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
13.09MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
697.00KUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-80.61MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-76.74MUSDFY2025 · Dec 31, 2025Free Cash Flow
-77.46MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
188.89MUSDFY2025 · Dec 31, 2025Interest Paid
611.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-80.61MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
213.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
11.69MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-1.33MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-769.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
788.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.72MUSDFY2025 · Dec 31, 2025Capital Expenditures
-719.00KUSDFY2025 · Dec 31, 2025Purchase of Investments
-154.75MUSDFY2025 · Dec 31, 2025Sale of Investments
60.25MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-95.22MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-6.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-400.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
10.76MUSDFY2025 · Dec 31, 2025Shares Outstanding
44.39MSharesUpdated Jul 18, 2026Float Shares
34.95MSharesUpdated Jul 18, 2026Shares Short
3.74MSharesUpdated Jul 18, 2026Short Ratio
5.74daysvs all stocks
Short % of Shares Outstanding
9.51%vs all stocks
% Held by Insiders
2.44%vs all stocks
% Held by Institutions
85.17%vs all stocks
Total Cash (MRQ)
383.19MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
8.62USDUpdated Jul 18, 2026Total Debt (MRQ)
4.03MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0106xCurrent Ratio (MRQ)
24.76xBook Value per Share (MRQ)
8.54USDUpdated Jul 18, 2026Total Assets
294.89MUSDvs all stocks (USD)
Total Current Assets
286.79MUSDFY2025 · Dec 31, 2025Total Liabilities
22.84MUSDFY2025 · Dec 31, 2025Total Non-current Assets
8.10MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.70MUSDFY2025 · Dec 31, 2025Total Current Liabilities
20.14MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
188.89MUSDFY2025 · Dec 31, 2025Other Short-term Investments
92.21MUSDFY2025 · Dec 31, 2025Accounts Receivable
769.00KUSDFY2025 · Dec 31, 2025Accounts Payable
2.67MUSDFY2025 · Dec 31, 2025Short-term Debt
3.23MUSDFY2025 · Dec 31, 2025Deferred Revenue
5.75MUSDFY2025 · Dec 31, 2025Other Current Liabilities
525.00KUSDFY2025 · Dec 31, 2025Long-term Debt
2.33MUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-333.42MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
272.05MUSDvs all stocks (USD)
52-Week Low
4.11USDUpdated Jul 18, 202652-Week High
25.95USDUpdated Jul 18, 202652-Week Change
395.86%vs all stocks
50-Day MA
19.72USDUpdated Jul 18, 2026200-Day MA
15.76USDUpdated Jul 18, 2026Avg 10-Day Volume
536.61KSharesUpdated Jul 18, 2026Avg 30-Day Volume
639.12KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-2.47USDUpdated Jul 18, 2026Other Income / Expense
-214.00KUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Sharp Decline With Volume And Volatility Expansion
A steep fall on heavy volume, leaving the price far below its peak.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.59
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $10.32M, lower than 95% of all stocks globallySignificant
Revenue (USD): 10,316,000Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Edan Instruments Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guangyuyuan Chinese Herbal Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hainan Haiyao Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Avalo Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pacira BioSciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Cisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Olema Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Ausun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangsu Aidea Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
KPC Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Wintao Communications Co.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion
Hertz Global Holdings, Inc.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion
TaskUs, Inc.
3 interpretationsDecline With Range Expansion And DrawdownUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion